Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Quality Lowdown: Key Inspection Findings At Glenmark, Centrient, Lupin, Aurobindo, Mac-Chem

Dec 15 2022

• By Bowman Cox

The Quality Lowdown

Related Content

GDUFA III Talks Completed; Fees will Fund Inspection, Complex Generic Improvements

Sep 02 2021

US FDA Warns Lupin Again About Poor Batch Failure Investigations

Oct 03 2019

FDA Warns Lupin To Stop Blaming Lab And Fix Manufacturing Processes

Nov 16 2017

Related Companies

Glenmark Pharmaceuticals Limited

Lupin Limited

Aurobindo Pharma Limited

Additional Topics

India Asia Pacific United States Manufacturing Quality Enforcement Compliance Ingredients BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window